LENZ Therapeutics Inc. (LENZ) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for LENZ Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
LENZ Therapeutics Inc. (LENZ) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $99M. It trades at $3.21, up 1.90% today. 6 analysts' average target of $22.00 implies +585.4% from today's price. Kronos AI's 30-day forecast is +53.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.00 |
| Low – high | $5.00 – $50.00 |
| Analysts | 6 |
| Upside to average | +585.4% |
Kronos AI 30-day forecast
| Expected close | $4.83 (+53.4%) |
| Likely range | +43.8% … +63.9% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator